Stratview Research publishes a new report titled Tissue Diagnostics Market which is segmented by Product Type (Consumables [Antibodies, Kits, Reagents, and Probes] and Instruments [Slide-Staining Systems, Scanners, Tissue-Processing Systems, and Other Instruments]), by Technology Type (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management, and Special Staining), by Disease Type (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, and Other Diseases), by End-User Type (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)
Tissue Diagnostics Market is expected to grow from USD 5.56 billion in 2022 to USD 8.23 billion by 2028 at a CAGR of 6.75% during the forecast period of 2022-2028 owing to the high prevalence of cancer and chronic diseases, infrastructure development for cancer diagnosis, and increasing healthcare expenditure coupled with growing health awareness. In addition, technological advancements in the field of tissue diagnostics and aging population are further expected to bolster the growth of the market during the forecast period.
Why is this report beneficial?
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
It also offers –
- Market Overview
- Key Manufacturers Profiles
- Market Analysis by Region
- Market Segment by Type
- Market Segment by Application
- Raw Material and Supply Chain
- Other Key Research Findings
All the data compiled by the market experts is the outcome of rigorous primary and secondary research conducted on the market players and reliable sources, including company white papers, journals, press releases, and more.
Key players active in the market –
The following are some of the key players in the Tissue Diagnostics Market:
- Abbott Laboratories
- Abcam plc.
- Agilent Technologies, Inc.
- Cancer Genetics Inc.
- Cell Signaling Technology, Inc.
- Danaher Corporation
- Hoffmann-La Roche Ltd
- Merck KGaA
- Sakura Finetek Japan Co., Ltd.
- Thermo Fisher Scientific Inc.
Click here to get a free sample copy of this report: https://www.stratviewresearch.com/Request-Sample/406/tissue-diagnostics-market-tissue.html#form
Customization of the report –
At Stratview Research, the market researchers make a note of opportunities, drawbacks/bottlenecks, estimations, and information related to the market using experienced skills and verified methodologies. Our research reports offer an exceptional experience of innovative solutions and outcomes to the users. If required, user can also opt for customization of the report.
Connect with our team at –